Producers of New PBS Series Joined By Experts to Reveal Science Behind... (to help us better understand what drives...)

Producers of New PBS Series Joined By Experts to Reveal Science Behind Happiness

Date:10/8/2009

to help us better understand what drives our emotions and what can lead us to happiness."

"With This Emotional Life we wanted to explore some of the problems real people are dealing with, what science tells us about the nature of those problems and how individuals can address these problems," added McGee. "What we found out is that good social relationships play an important role in improving our overall wellbeing."

Psychologist Dr. Jessica Zucker provided insights into how research on human emotions has informed her work with mothers and infants. "We are just beginning to understand scientifically the importance of parent - infant interactions in laying the foundation for healthy relationships with siblings, friends, co-workers and lovers," Zucker said.

The panel also included Lois Ross, who appears in the documentary with her son Jason, a 29 year-old sonographer living in New York who was diagnosed with Asperger's Syndrome, a neurological disorder that makes it difficult to read others' emotions. Ross is among several parents profiled in This Emotional Life who have helped their children understand social and relationship skills that did not come naturally.

"There's one thing about Jason and it always warms my heart," Ross said. "He never gives up. In the face of adversity, he just keeps going along."

In the series, viewers have a front-row seat with panelist Dr. Xavier Amador as he worked with a couple who made a connection, but are now struggling to save it.

"Our ability to sustain and grow healthy relationships get tested almost daily when we pick a life partner and start out own family," Amador said. "Research shows that many people can heal and nurture failing relationships by applying well studied, but underutilized, psychological principles. Marriage therapy is a tremendously important, powerful tool to which more people should become open."

The film is
'/>"/>

SOURCE Vulcan Productions
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5
Related medicine news :

1. Association of Peruvian Anchovy Producers Pursues MSC Certification
2. Got Moving Stories? Calling All Reporters, Writers, Producers and Editors
3. First-Person Stories Gathered on Web Shape New Nonfiction TV Series from Veteran Producers
4. Whole Foods Market(R) Lends $2.5 Million to Local Growers, Producers and Food Artisans
5. John Hancock Expands LTC Training Effort with ClearCert High Usage By Producers and Streamlines Process for Insurers
6. Medical Device Producers Express Interest in Purolator USA's Express Service and Customer Service
7. United Concordia Unveils New Online Capabilities for Producers
8. Lumension Launches New Optimal IT Security Videocast Series
9. iJETs Survive/Thrive Webinar Series Continues With Pandemic Influenza: Where Do We Stand?
10. DST Systems, Inc. Announces Exchange Transaction Involving 4.125% Series A Convertible Senior Debentures
11. Market Welby Hosting Free Urgent Care and Medical Practice Fast Growth Marketing Webinar Series

Post Your Comments:

(Date:12/15/2009)... 15 Reportlinker.com announces that ... available in its catalogue: ,, ... Therapeutics - Market Forecasts to 2015, ... Analysis ,, http://www.reportlinker.com/p0168099/The-Future-of-Respiratory-Diseases-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html ... The author has released its latest ...

(Date:12/15/2009)... NEW YORK, Dec. 15 ... research report is available in its ... of Autoimmune Diseases Therapeutics - Market ... Pipeline and Deals Analysis ... Summary ,, The author has ...

(Date:12/15/2009)... ALPHARETTA, Ga., Dec. 15 Hosted by ... the 4th annual event recognized 2009,s best eLearning ... all, were spread across 4 categories. The ... developed for the world,s largest hotelier, was selected ... Hours of Custom eLearning" category by the panel ...

(Date:12/15/2009)... Ill. and CHENNAI, India, Dec. 15 /PRNewswire-FirstCall/ ... ), the world leader in generic injectable ... (BSE: 524372, NSE: ORCHIDCHEM), a leading Indian ... beta-lactam antibiotics manufacturers globally, today announced an ... injectable finished-dosage form pharmaceuticals business for approximately ...

(Date:12/15/2009)... is being released by the American Health Information Management ... RHIT, CCS, FAHIMA ,, AHIMA President ... ,, On behalf of the A-H-I-M-A Board of Directors...it ... executive officer, Doctor Alan Dowling... ,, Back last summer ... who we knew could effectively replace Linda ...

[0] Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis [0] Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis [0] The Venza Group Received Top Honors at the American Society of Training & Development (ASTD) eLearning Excellence Awards Ceremony Held on December 10, 2009 [0] Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business [0] Dowling Press Availability Tuesday, December 15, 2009 / 10:00 a.m. CST

... more than 60 orders for faster form of image-guided ... intensity-modulated radiation therapy, PALO ... ) today announced it has received more than 60 orders ... RapidArc orders have been,concentrated in North America but have also ...

... The NCCA accredited the National,Exercise & ... a five-year period, expiring March 31, 2013, ... NESTA is a professional certification organization,acting in ... education,examination, experience and ethics requirements for certification., ...

... Association urges Senators Cardin and Mikulski to quickly pass,companion ... 23 AARP thanked the,supporters and cosponsors of the ... today in the U.S. House of Representatives. The bill,prevents ... stopping,harmful cuts proposed by the administration., "Today,s vote ...

... Expert says goal is to maintain strength, not gain it, ... If you,re an athlete or fitness enthusiast who suffers a ... have to stop exercising. , , "Exercise can definitely be ... its type, the injured area should be moved and not ...

... and Tour Groups, CHICAGO, April 23 ... Bank of America Chicago Marathon has closed as ... race, marking the event,s,established capacity. A limited number ... tour groups., (Logo: http://www.newscom.com/cgi-bin/prnh/20050720/CLW086LOGO-b ), ...

... with these headaches suffer from skin discomfort, study finds, ... have migraines -- either chronic or episodic -- are ... sensitivity, new research shows. , As many as two-thirds ... condition called cutaneous allodynia. Cutaneous allodynia is skin sensitivity ...

Other Medicine News:Health News:Varian Medical Systems Announces Record Demand for New RapidArc(TM) Radiotherapy Treatment Capability 2 Health News:Varian Medical Systems Announces Record Demand for New RapidArc(TM) Radiotherapy Treatment Capability 3 Health News:Varian Medical Systems Announces Record Demand for New RapidArc(TM) Radiotherapy Treatment Capability 4 Health News:Varian Medical Systems Announces Record Demand for New RapidArc(TM) Radiotherapy Treatment Capability 5 Health News:The National Exercise & Sports Trainers Association Receives Accreditation of Its Personal Fitness Trainer Certification From the National Commission for Certifying Agencies (NCCA) 2 Health News:AARP Thanks Maryland's Representatives for Supporting Bill to Protect People in Medicaid 2 Health News:Exercise Plays Role in Recovery From Sports Injuries 2 Health News:2008 Bank of America Chicago Marathon Registration Closes as Race Reaches 45,000 Participant Capacity 2 Health News:Skin Pain, Sensitivity Rises With Migraine 2 Health News:Skin Pain, Sensitivity Rises With Migraine 3

Varian Medical Systems Announces Record Demand for New RapidArc(TM) Radiotherapy Treatment Capability The National Exercise & Sports Trainers Association Receives Accreditation of Its Personal Fitness Trainer Certification From the National Commission for Certifying Agencies (NCCA)AARP Thanks Maryland's Representatives for Supporting Bill to Protect People in Medicaid Exercise Plays Role in Recovery From Sports Injuries 2008 Bank of America Chicago Marathon Registration Closes as Race Reaches 45,000 Participant Capacity Skin Pain, Sensitivity Rises With Migraine

(Date:12/15/2009)... -- Masimo (Nasdaq: MASI ), the inventor ... Perfusion pulse oximetry, today announced that Masimo Chairman ... 2009 Frost & Sullivan CEO of the Year ... According to Frost & Sullivan, the award is ... in understanding customer requirements, developing new technologies, delivering ...

(Date:12/15/2009)... MALVERN, Pa. and WALTHAM, Mass., Dec. 15 /PRNewswire/ ... find that methicillin-resistant Staphylococcus aureus (MRSA) ... infectious disease specialists with regard to their treatment ... activity against MRSA is among the top factors ... skin and skin structure infections. Other key factors ...

(Date:12/15/2009)... -- Bend Research Inc. announced,today that its clients may ... used in technologies developed by the firm to enhance ... Bend Research clients may now reference a ... filings with the FDA, Bend Research officials said. , ... development and know it will assist our,clients in accelerating ...

Breaking Medicine Technology:Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 2 Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 3 Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 4 Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 5 Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 6 A Drug's Activity Against MRSA is Among the Top Factors That Influences European Physician Antibiotic Selection for Treating Skin and Skin Structure Infections 2 A Drug's Activity Against MRSA is Among the Top Factors That Influences European Physician Antibiotic Selection for Treating Skin and Skin Structure Infections 3 Bend Research Clients May Now Reference Key Safety Document for Important Solubility Excipient 2 An atomic level look at an HIV accomplice 61728 1 An atomic level look at an HIV accomplice 61728 2 Bioreactor for bone tissue engineering wins professor venture fair 10813 1 Bioreactor for bone tissue engineering wins professor venture fair 10813 2 Bioreactor for bone tissue engineering wins professor venture fair 10813 3 Drug studied as possible treatment for spinal injuries 10811 1 Drug studied as possible treatment for spinal injuries 10811 2 Drug studied as possible treatment for spinal injuries 10811 3

[0] Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award [0] A Drug's Activity Against MRSA is Among the Top Factors That Influences European Physician Antibiotic Selection for Treating Skin and Skin Structure Infections [0] Bend Research Clients May Now Reference Key Safety Document for Important Solubility Excipient

... in Repeat-Dosing Study in Subjects with ALS, RICHMOND, ... ) announced today that it has opened a Phase,2 ... subjects,with ALS, a progressive, degenerative motor-neuron disease for which ... drug, SB-509, is an injectable formulation of a plasmid,encoding ...

... Sept. 3 Forest Laboratories, Inc.,(NYSE: ... announced results from,two global Phase III studies ... for the treatment of patients with chronic,obstructive ... I&II,(AClidinium CLinical Trial Assessing Efficacy and Safety ...

Other Medicine Technology:Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 2 Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 3 Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 4 Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 5 Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 2 Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 3 Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 4 Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 5 Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 6

Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS)Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD)

... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...

... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...

... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...

Medicine Products:

Allergen, Weed, Kochia/Firebush Allergen, Tree, Willow Tree Allergen, Tree, White Ash Tree Allergen, Tree, White Pine Tree

Producers of New PBS Series Joined By Experts to Reveal Science Behind...(to help us better understand what drives...),Health